Delta Electronics (Supplementary Announcement): Subsidiary ACT Genomics Holdings Company Limited Announces Board Resolution to Increase Capital for ACT TW
NQ Score
73/100
AI Summary (NQ-processed)
Delta Electronics' subsidiary, ACT Genomics Holdings Company Limited (ACT KY), announced a board resolution to increase the capital of its wholly-owned subsidiary, ACT TW. The capital increase involves approximately 125 million shares at NT$10 per share, totaling about NT$1.25 billion. This move aims to meet the funding needs of the subsidiary, bringing ACT KY's cumulative holding in ACT TW to 100% with a total investment of approximately NT$1.499 billion.
AI analysis data is not yet available.